Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
Price Target
Average
266.57%
Revenue Forecast
Estimate
325.82%
EBIT
Estimate
28.54%
Net Income
Estimate
9.47%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioXcel Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for BTAI of $17.7 , with forecasts ranging from
a
low of
$1 to a high of $73 .
BTAI Lowest Price Target
Wall Street Target
1 USD
-79.31%
BTAI Average Price Target
Wall Street Target
17.7 USD
266.57%
BTAI Highest Price Target
Wall Street Target
73 USD
1410.61%
REVENUE FORECAST
Revenue Forecast Chart BTAI
EBIT FORECAST
EBIT Forecast Chart BTAI
NET INCOME FORECAST
Net Income Chart BTAI